Overview
Portfolio
More
Tampabaywave
Tampa, United States
Focus on accelerating Florida’s innovation ecosystem by supporting early‑stage startups to build scalable businesses that generate social and economic impact.
Portfolio
16+
Employees
50+
Founded
2008
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Tampabaywave
Focus on accelerating Florida’s innovation ecosystem by supporting early‑stage startups to build scalable businesses that generate social and economic impact.
Portfolio
16+
Employees
50+
Founded
2008
AUM
N/A
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Showing 15 of 15 matched portfolio companies
The startup is developing a portable handheld emergency tamponade device designed to be inserted into knife and gunshot wounds to minimize catastrophic blood loss. This technology aims to improve the response of medical first responders in cases of penetrative trauma, ultimately reducing mortality rates associated with violent injuries.
Funding: $320.0K
Rough estimate of the amount of funding raised
Funding: $320.0K
Rough estimate of the amount of funding raised
Architect Health provides an AI‑powered vendor management platform for health insurers, Medicaid/Medicare plans, and health systems. The platform centralizes evaluation, procurement, and ongoing optimization of digital health solutions by ingesting population data, scoring vendors on measurable outcomes, and offering a searchable marketplace with real‑time analytics on cost savings and health impact.
Funding: $1.1M
Rough estimate of the amount of funding raised
Funding: $1.1M
Rough estimate of the amount of funding raised
Asante Bio develops regenerative orthobiologic implants using proprietary additive biomanufacturing techniques that enhance the mechanical properties of biopolymers for orthopedic applications. The company addresses the need for effective joint preservation solutions in orthopedics and sports medicine by creating high-performance devices that improve biological healing and surgical outcomes.
Founded 2021
CurieDx develops an AI-driven mobile app that analyzes smartphone images to provide instant screening predictions for common illnesses like strep throat, enhancing the accuracy of remote diagnostics by 40%. This technology enables patients to conduct preliminary assessments at home and facilitates timely telehealth consultations for appropriate medical care.
Endless Health provides wellness professionals with an integrated platform featuring precision testing, practice management software, and strategic launch support. The company streamlines operations by offering tools for clinical tracking, client management, and compliant service delivery. This infrastructure enables longevity practices to personalize care strategies and scale their businesses efficiently.
Funding: $4.5M
Rough estimate of the amount of funding raised
Funding: $4.5M
Rough estimate of the amount of funding raised
Eniax utilizes a conversational AI system, Patricia, to automate appointment management in healthcare, significantly reducing patient no-shows by up to 50% within the first month. This technology addresses the issue of missed appointments, which costs healthcare institutions billions annually, while enhancing patient communication and satisfaction across multiple platforms.
ExactRx automates pre-procedural clearance and claims preparation by aligning payer policy with clinical workflows. The platform evaluates existing documentation against payer rules and clinical guidelines to flag missing information before submission. This process reduces claim denials and delays, allowing provider teams to focus on patient care.
Goldfinch Health provides a digital navigation platform that guides patients through pre‑operative preparation and post‑operative recovery with evidence‑based, non‑opioid pain‑management protocols, real‑time clinician support, and automated alerts for complications. The solution offers analytics dashboards and EHR integration for hospitals, insurers, and employers to monitor outcomes, reduce opioid use, and lower readmission costs.
Hera Fertility provides comprehensive male fertility testing, including semen analysis and DNA fragmentation assessments, available via at-home kits or 500+ national lab locations. The platform delivers physician-backed, AI-powered analysis of test results, offering personalized action plans to improve sperm health. Users can also upload existing lab reports for free interpretation and a customized fertility score.
Funding: $170.0K
Rough estimate of the amount of funding raised
Funding: $170.0K
Rough estimate of the amount of funding raised
Kelli Care uses targeted AI outreach via calls and texts to automate patient follow-through and administrative tasks. This system configures outreach rules, conducts personalized patient conversations, and delivers EHR-ready reports for clinical action. The platform enables care teams to focus on service delivery while boosting patient throughput and operational ROI.
Provides AI-powered, personalized health protocols and science-based solutions for women aged 35 and older, focusing on peri/menopausal symptoms and longevity. The platform combines expert-curated products, including supplements and wearables, to address issues like hot flashes, sleep disturbances, and mood swings, offering tailored strategies for improved wellness at every stage of life.
Nurtur is a digital health application that utilizes AI to identify women at risk for postpartum depression during pregnancy and enrolls them in evidence-based self-guided therapy programs. By collaborating with OBGYNs, Nurtur enhances maternal mental health care and provides timely support to prevent the onset of postpartum depression.
This AI-powered CRM helps healthcare providers personalize patient experiences and strengthen relationships with patients and physician networks. The platform aims to accelerate revenue growth through improved patient management and communication.
Paterna Biosciences focuses on developing solutions to address male infertility using adult stem cell technology. The company's sole focus is restoring fertility by utilizing the patient's own stem cells to potentially resolve underlying genetic disorders. This work is strictly limited to therapeutic applications for infertility and does not involve heritable trait modification.
Funding: $8.0M
Rough estimate of the amount of funding raised
Funding: $8.0M
Rough estimate of the amount of funding raised
PatientX provides the life science industry with standardized patient experience measurement using scientifically validated instruments. This unbiased, third-party data quantifies patient needs and expectations to improve clinical trial outcomes and retention. Real-time, AI-enabled analytics help sponsors and sites take corrective action to enhance patient-centric approaches and comply with FDA guidance.
Showing 1 of 1 unmatched portfolio company